EUCTR2009-011978-15-IT进行中（未招募）不适用
Effectiveness of acetylcysteine in first line therapy to cure Helicobacter pylori. Pilot study. - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年4月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •both genders, age > 18 years, infection from Helicobacter pylori, at gastroscopy or 13C urea breath test.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Verified allergies to the acetylcysteine or to the antibiotics to cure Helicobacter pylori, pregnancy, nursing.
研究者
相似试验
进行中（未招募）
不适用
Effectiveness of acetylcysteine in ?rescue? therapy for Helicobacter pylori infection. Pilot Study - NDDuodenal and gastric ulcer recurrence with Helicobacter P. infectionMedDRA version: 9.1Level: LLTClassification code 10065231MedDRA version: 9.1Level: LLTClassification code 10051790EUCTR2009-011979-76-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
已完成
3 期
acetylcysteine in the treatment of diarrhea caused by rotavirusDiarrhea caused by rotavirus.A08.0Rotaviral enteritisIRCT20181208041882N13Yazd University of Medical Sciences64
进行中（未招募）
1 期
Efficacy and safety of acetylcysteine for the treatment of acute uncomplicated rhinosinusitisAcute rhinosinusitisMedDRA version: 20.0Level: LLTClassification code 10052106Term: RhinosinusitisSystem Organ Class: 100000004862EUCTR2019-000060-20-DEHEXAL AG944
进行中（未招募）
1 期
Efficacy and safety of acetylcysteine for the treatment of acute uncomplicated rhinosinusitisEUCTR2019-000060-20-BGHexal AG944
已完成
不适用
Evaluating N-acetylcysteine efficacy in the prevention of amphotericin B-induced nephrotoxicityFungal infections.Certain infectious and parasitic diseasesB37? B38 ?IRCT201107233449N8Tehran University of Medical Sciences60